... a newly synthesized αpblocker, YM-12617, was tried and evaluated in 77 male patients with mild benign prostatic hyperplasia and in 5 women with micturition difficulties of unknown origin. Both 0.2- and 0.4-mg doses relieved the difficulty in about 80% of the patients, subjectively and objectively...